- ►diabetesjournals.org R Scott, R O'Brien, G Fulcher, C Pardy, M d … - Diabetes Care, 2009 - Am Diabetes Assoc RESULTS—More than 80% of FIELD participants met the ATP III criteria for
metabolic syndrome. Each ATP III feature of metabolic syndrome, apart from
increased waist circumference, increased the absolute risk of CVD events ... Cited by 8 - Related articles - All 3 versions
AC Goldberg, HE Bays, CM Ballantyne, MT … - The American Journal of Cardiology, 2009 - Elsevier In patients with mixed dyslipidemia characterized by increased triglycerides
(TG), decreased high-density lipoprotein (HDL) cholesterol, and increased
low-density lipoprotein (LDL) cholesterol, monotherapy with lipid-altering ... Cited by 5 - Related articles - All 27 versions
T Filippatos, HJ Milionis - Expert Opin. Investig. Drugs, 2008 - informahealthcare.com Background: Fenofibrate is the most widely used fibrate. Its efficacy and
tolerability in the treatment of hypertriglyceridaemia and combined
hyperlipidaemia have been demonstrated in several clinical trials. ... Cited by 5 - Related articles - All 5 versions
MM Vasudevan, CM Ballantyne - Endocrine Practice - AACE Page 1. 1 Advances in Lipid Testing and Management in Diabetics Madhuri
M. Vasudevan, MD, MPH Christie M. Ballantyne, MD Center for ... Related articles - All 2 versions
WH Smiley, BV Khan, LS Sperling - Current Treatment Options in Cardiovascular Medicine, 2009 - Springer The 3-hydroxy-3-methylglutaryl coenzyme A reduc- tase inhibitors (statins) have
a compelling track record. Large-scale clinical trials consistently have
demonstrated their effectiveness in reducing car- diovascular events and ... Related articles - All 2 versions
SFE Praet, LJC van Loon - Acta Diabetologica - Springer Abstract Structured exercise is considered an important cornerstone to achieve
good glycemic control and improve cardiovascular risk profile in Type 2
diabetes. Current clinical guidelines acknowledge the therapeutic strength ... Related articles - All 4 versions
C Fiévet, B Staels - Current Opinion in Lipidology, 2009 - pdfs.journals.lww.com Introduction An elevated LDL cholesterol (LDL-C) level is a major risk factor
for cardiovascular disease (CVD), and several randomized clinical trials have
shown that lowering LDL-C levels with statins results in a substantial ... Related articles - All 4 versions
AS Wierzbicki - Current Opinion in Cardiology, 2009 - journals.lww.com Recent findings: Endpoint studies have been conducted with fibrates in coronary
heart disease (CHD) since 1971 and initial results were contradictory. Fibrates
later showed benefits in patients with low HDL-C and low LDL-C. The ... Related articles - All 4 versions
DC Berry, N Noy - Molecular and Cellular Biology, 2009 - Am Soc Microbiol Page 1. 1 All-trans-retinoic acid represses obesity and insulin resistance by
activating both PPARβ/δ and RAR Daniel C. Berry and Noa Noy* ... Cited by 1 - Related articles
